BioHorizons pulls plug on IPO

BioHorizons, which sells dental implants and related products, has withdrawn its plans for an initial public offering (IPO), citing poor market conditions.

The company originally announced the proposed $90 million IPO in January 2011 but postponed the deal less than a month later.

In addition to dental implants, BioHorizons manufactures tissue-regeneration products for the replacement of missing teeth. Its implant products are based on a proprietary Laser-Lok platform technology and biomechanically engineered threads.

Page 1 of 22
Next Page